VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
44 hedge funds and large institutions have $61.4M invested in VIVEVE MED INC in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $68.1M → $61.4M (-$6.71M)
10% less funds holding
Funds holding: 49 → 44 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$1.04M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$661K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$323K |
| 4 |
State Street
Boston,
Massachusetts
|
+$161K |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$130K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.55M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.05M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$1.05M |
| 4 |
Neuberger Berman Group
New York
|
-$419K |
| 5 |
AFS
Amtrust Financial Services
New York
|
-$250K |
VIVE Hedge Fund Activity: Q4 2017 in Review
44 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2017, worth a combined $61.4M — down 9.9% from $68.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of VIVE and 6 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 16 added.
The largest buyer was RTW Investments, adding an estimated $1.04M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.55M sold.
- 44 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2017, down from 49 in Q3 2017.
- Funds reported $61.4M of VIVEVE MED INC stock for Q4 2017, down 9.9% quarter-over-quarter.
- 6 funds opened new VIVEVE MED INC positions in Q4 2017 and 11 closed out, a net change of -5 holders.
- The largest VIVEVE MED INC buyer in Q4 2017 was RTW Investments, an estimated $1.04M added.
- The largest VIVEVE MED INC seller in Q4 2017 was Perceptive Advisors, an estimated $2.55M sold.
Based on aggregated 13F filings for Q4 2017.